Can the evaluation of novel surveillance methods be factored into their implementation? • Will monitoring target populations (e.g. food service handlers, MG employees) be a necessary and/or feasible approach to augmenting routine surveillance? • Is there access to suitable laboratory facilities to confirm or exclude diagnoses?